Vaxcyte Share Price Today
(NASDAQ: PCVX)

Name: Vaxcyte Share Price Today (NASDAQ: PCVX) - Vaxcyte Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Vaxcyte share price is $79.74 & ₹6,915.53 as on 22 Feb 2025, 2.30 'hrs' IST

$79.74

▲

-2.73

(-3.31%)

Market is closed - opens 8 PM, 24 Feb 2025

View live Vaxcyte share price in Dollar and Rupees. Guide to invest in Vaxcyte stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vaxcyte, along with analyst recommendations, forecasts, and comprehensive financials.

Vaxcyte share price movements

Today's Low: $79.54
Today's High: $84.01
$79.74
0.25%
Downside
Day's Volatility :5.32%
Upside
5.08%
52 Weeks Low: $58.10
52 Weeks High: $121.06
$79.74
27.14%
Downside
52 Weeks Volatility :52.01%
Upside
34.13%

Vaxcyte (PCVX) Returns

Period	Vaxcyte Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-13.04%	1.6%	0.0%
6 Months	0.33%	-5.8%	0.0%
1 Year	0.98%	-1.0%	0.0%
3 Years	252.83%	15.7%	-9.0%

Vaxcyte (PCVX) Key Statistics

in dollars & INR

Previous Close	$82.47
Open	$83.77
Today's High	$84.01
Today's Low	$79.54
Market Capitalization	$10.3B
Today's Volume	$1.2M
52 Week High	$121.055
52 Week Low	$58.1
Revenue TTM	$0.0
EBITDA	$-599.0M
Earnings Per Share (EPS)	$-4.6
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-21.06%

How to invest in Vaxcyte Stock (PCVX) from India?

It is very easy for Indian residents to invest directly in Vaxcyte from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vaxcyte stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vaxcyte or PCVX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vaxcyte or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vaxcyte shares which would translate to 0.011 fractional shares of Vaxcyte as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Vaxcyte, in just a few clicks!

Returns in Vaxcyte (PCVX) for Indian investors in Rupees

The Vaxcyte stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Vaxcyte investment value today

Current value as on today

₹1,05,624

Returns

₹5,624

(+5.62%)

Returns from Vaxcyte Stock

₹975 (+0.98%)

Dollar Returns

₹4,649 (+4.65%)

Indian investors sentiment towards Vaxcyte (PCVX)

-38%

Period: Jan 24, 2025 to Feb 23, 2025. Change in 30 Days versus previous period

Search interest for Vaxcyte Stock from India on INDmoney has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Vaxcyte

FMR Inc
12.68%
Vanguard Group Inc
9.60%
HHG PLC
8.76%
BlackRock Inc
8.56%
RA Capital Management, LLC
6.97%
Capital Research Global Investors
4.98%

Analyst Recommendation on Vaxcyte

Buy

93%Buy

6%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Vaxcyte(by analysts ranked 0 to 5 stars)

Based on 15 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Vaxcyte Stock (PCVX)

What analysts predicted

Upside of 87.97%

Target:

$149.89

Current:

$79.74

Insights on Vaxcyte Stock (Ticker Symbol: PCVX)

Price Movement
In the last 3 years, PCVX stock has moved up by 294.0%
PCVX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 59.0% return, outperforming this stock by 55.3%

Vaxcyte Technicals Summary

Sell

Neutral

Buy

Vaxcyte is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Vaxcyte (PCVX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Vaxcyte Inc	-11.04%	0.33%	0.98%	252.83%	277.74%
Biontech Se	1.58%	37.14%	28.33%	-20.32%	255.59%
Regeneron Pharmaceuticals, Inc.	3.63%	-41.61%	-29.21%	13.2%	52.94%
Vertex Pharmaceuticals Incorporated	10.15%	0.33%	11.71%	110.26%	108.69%
Alnylam Pharmaceuticals, Inc.	-10.11%	-6.89%	57.94%	61.67%	112.27%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Vaxcyte Inc	NA	NA	NA	-3.91	-0.21	-0.15	NA	27.47
Biontech Se	160.8	NA	0.04	-3.29	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	18.16	18.16	1.01	43.09	0.16	0.07	0.01	273.57
Vertex Pharmaceuticals Incorporated	32.84	NA	1.3	18.11	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.59	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Vaxcyte Inc	Buy	$10.3B	277.74%	NA	0.0%
Biontech Se	Buy	$28.3B	255.59%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$76.1B	52.94%	18.16	31.07%
Vertex Pharmaceuticals Incorporated	Buy	$123.3B	108.69%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$32.5B	112.27%	NA	-12.37%

Vaxcyte Dividend announcements

Vaxcyte Earnings
Vaxcyte’s price-to-earnings ratio stands at None
Read More

About Vaxcyte

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

Organization	Vaxcyte
Employees	254
CEO	Mr. Grant E. Pickering M.B.A.
Industry	Health Technology

Management People of Vaxcyte

Name	Title
Mr. Grant E. Pickering M.B.A.	Co-Founder, CEO & Director
Mr. Andrew L. Guggenhime M.B.A.	President & CFO
Mr. James Wassil M.B.A., M.S.	Executive VP & COO
Mr. Mikhail Eydelman J.D.	Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary
Dr. Jeff Fairman Ph.D.	Co-Founder & VP of Research
Ms. Janet Graesser	Senior Vice President of Corporate Communications & Investor Relations
Ms. Whitney Jones	Chief People Officer
Mr. Paul W. Sauer M.B.A.	Senior Vice President of Process Development & Manufacturing
Mr. Harp Dhaliwal M.B.A.	Chief Technical Operations Officer
Sam Iki	Senior Vice President of Project Management

Important FAQs about investing in PCVX Stock from India :

What is Vaxcyte share price today?

Vaxcyte share price today stands at $79.74, Open: $83.77 ; Previous Close: $82.47 ; High: $84.01 ; Low: $79.54 ; 52 Week High: $121.06 ; 52 Week Low: $58.10.

The stock opens at $83.77, after a previous close of $82.47. The stock reached a daily high of $84.01 and a low of $79.54, with a 52-week high of $121.06 and a 52-week low of $58.10.

Can Indians buy Vaxcyte shares?

Yes, Indians can invest in the Vaxcyte (PCVX) from India.

With INDmoney, you can buy Vaxcyte at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Vaxcyte at zero transaction cost.

How can I buy Vaxcyte shares from India?

It is very easy to buy Vaxcyte from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vaxcyte (PCVX) be purchased?

Yes, you can buy fractional shares of Vaxcyte with INDmoney app.

What are the documents required to start investing in Vaxcyte stocks?

To start investing in Vaxcyte, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.